Partners Capital Investment Group, LLP Bridge Bio Pharma, Inc. Transaction History

Partners Capital Investment Group, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $10,885 - $16,945	-1,371 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$7.34 - $17.16 $3.55 Million - $8.29 Million	-483,002 Reduced 99.72%	1,371 $14,000
Q4 2021 Feb 14, 2022	BUY	$11.38 - $53.41 $184,868 - $867,645	16,245 Added 3.47%	484,373 $8.08 Million
Q3 2021 Nov 15, 2021	BUY	$46.87 - $64.24 $1.44 Million - $1.97 Million	30,674 Added 7.01%	468,128 $21.9 Million
Q2 2021 Aug 16, 2021	BUY	$46.47 - $63.93 $20.3 Million - $28 Million	437,454 New	437,454 $26.7 Million

315

177M

11.2M

2.29M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Partners Capital Investment Group, LLP with notifications on news.